• Chloroquine and Everolimus in Melanoma: Apoptosis and Lipids

  2026-09-03

  Ciołczyk-Wierzbicka and colleagues showed that combining chloroquine with the mTOR inhibitor everolimus reduced melanoma-cell proliferation, activated apoptotic signaling, and altered lipid distribution. The study’s main contribution is an integrated experimental framework that connects caspase activation and DNA fragmentation with nuclear, cytoskeletal, and lipid-associated fluorescence phenotypes.

• Calnexin Shapes CFTR Variant Rescue

  2026-09-03

  Tedman et al. used deep mutational scanning to show that the ER chaperone calnexin influences both CFTR surface expression and corrector responsiveness across 232 clinical variants. The study provides a mechanistic framework for interpreting genotype-specific rescue and for designing more informative cystic fibrosis research assays.

• Firefly Luciferase mRNA: Reporter & Workflow

  2026-09-02

  Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP) is a modified, polyadenylated reporter transcript for sensitive gene expression assays, cell viability assays, and in vivo imaging. Its standardized formulation and handling guidance support reproducible transfection controls, while assay output remains dependent on delivery, substrate, ATP, oxygen, and cell state.

• Hexa-Acylated LPS and Cancer Immunotherapy Response

  2026-09-02

  The reference study identifies the structural form of gut microbiota-derived lipopolysaccharide, rather than bacterial taxonomy alone, as a determinant of anti-PD-1 immunotherapy response. Its metagenomic, in vitro, and mouse-model experiments support hexa-acylated LPS as both a functional biomarker and a possible enhancer of antitumor immunity, while highlighting the risks of nonspecific microbiome perturbation.

• Mitochondrial Permeability Transition Pore Assay Kit

  2026-09-01

  Discover how the Mitochondrial Permeability Transition Pore Assay Kit converts pore opening into a functional Calcein AM fluorescent probe readout. This guide connects assay design with recent evidence on mitochondrial ROS, cardiolipin peroxidation, and intrinsic apoptosis.

• TBST (Tris-Buffered Saline and Tween 20) Guide

  2026-09-01

  TBST is a ready-to-use Tris-buffered saline solution containing Tween 20 for blocking, antibody dilution, and washing in Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry. It is intended to reduce nonspecific binding and background, but should be avoided or validated carefully when non-ionic detergents interfere with assay chemistry, antigen integrity, or detection.

• Carbapenemase Gene Spread in Enterobacter cloacae

  2026-08-31

  A 2025 BMC Microbiology study maps carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae across eight teaching hospitals in Guangdong, combining gene localization, conjugation, mobile-element analysis, and strain typing. Its findings show that blaNDM-1 was frequently plasmid-associated and readily transferable, highlighting the importance of surveillance that measures both resistance mechanisms and transmission potential.

• TPCA-1: IKK-2 Inhibitor Workflow

  2026-08-31

  TPCA-1 is a selective IKK-2 inhibitor for separating NF-κB-driven cytokine responses from RIPK1-dependent apoptosis and necroptosis. This workflow combines pathway, cytokine, viability, and phospho-protein readouts to improve mechanistic interpretation in inflammation research and rheumatoid arthritis research.

• NU7441: From DNA-PK Mechanism to Translation

  2026-08-30

  NU7441 (KU-57788) is more than a potent DNA-PK inhibitor: it is a translational research tool for testing how DNA damage response defects, cell-cycle control, and treatment sensitivity intersect. This article connects mechanistic biology with experimental design, selectivity analysis, and oncology-focused decision-making.

• Temafloxacin: PK-Informed Antibacterial Assays

  2026-08-29

  Temafloxacin is a fluoroquinolone broad-spectrum antibacterial agent with distinctive pharmacokinetic features that can improve assay design. This guide connects exposure, tissue distribution, intracellular testing, and practical compound handling without repeating a conventional pathogen-by-pathogen review.

• From ROS Signal to Translational Strategy

  2026-08-28

  A mechanistic and strategic guide to using live-cell ROS measurements to connect oxidative stress, Nrf2 and EGFR/PI3K/AKT biology with translational decisions in respiratory, apoptosis and cancer research.

• RNA Pol II Inhibition and Regulated Cell Death

  2026-08-28

  Harper et al. identify an active apoptotic response to loss of hypophosphorylated RNA Pol II, challenging the idea that transcriptional inhibition kills cells only through passive mRNA and protein decay. Their functional-genomics framework defines the Pol II degradation-dependent apoptotic response and offers a strategy for reinterpreting the lethality of transcription-targeting drugs.

• Carbapenemase Gene Transmission in CREC

  2026-08-27

  This Guangdong multicenter study maps carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae and distinguishes plasmid-mediated horizontal transfer from strain-level dissemination. Its combination of plasmid elimination, PCR, conjugation, antimicrobial susceptibility testing, and ERIC-PCR provides a practical framework for hospital resistance surveillance.

• Epmedin C Limits DON Immunotoxicity in Chicken Macrophages

  2026-08-27

  The reference study identifies caspase-1/IL-1β signaling as a central component of low-dose deoxynivalenol immunotoxicity in chicken macrophages and shows that epmedin C can attenuate this response. By combining cellular experiments, network pharmacology, molecular docking, coculture analysis, and chick validation, the work connects oxidative stress with inflammatory immune dysfunction and suggests a poultry-focused detoxification strategy.

• Oleanolic Acid, FXR, and Cholestatic Liver Injury

  2026-08-26

  The 2024 reference study defines a mechanistic link between oleanolic acid exposure, impaired FXR-regulated bile acid efflux, and disruption of hepatocyte tight junctions. Its combined transporter, imaging, and pharmacological-rescue design provides a useful framework for studying cholestasis and FXR signaling pathway dysfunction.

8375 records 1/559 page Next 12345 下5页 Last page